MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

12 Feb 2024 Evaluate
The revenue zoomed 21.51% to Rs. 848.12 millions for the quarter ended December 2023 as compared to Rs. 697.98 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended December 2023 rise to 46.00% to Rs. 88.96  millions  compared to R. 60.93 millions in corresponding previous quarter.Operating profit surged to 151.38 millions from the corresponding previous quarter of 103.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 848.12 697.98 21.51 2333.63 1983.28 17.67 2750.52 3186.67 -13.69
Other Income 41.88 29.52 41.87 117.54 100.59 16.85 76.12 126.40 -39.78
PBIDT 151.38 103.81 45.82 434.35 223.54 94.31 356.96 782.09 -54.36
Interest 2.75 2.57 7.00 8.80 8.75 0.57 11.97 15.62 -23.37
PBDT 148.63 101.24 46.81 425.55 214.79 98.12 344.99 766.47 -54.99
Depreciation 20.67 20.04 3.14 60.83 59.81 1.71 78.99 76.73 2.95
PBT 127.96 81.20 57.59 364.72 154.98 135.33 266.00 689.74 -61.43
TAX 39.00 20.27 92.40 88.01 39.29 124.00 64.81 167.28 -61.26
Deferred Tax 3.85 2.26 70.35 6.63 -3.32 -299.70 -7.29 -4.22 72.75
PAT 88.96 60.93 46.00 276.71 115.69 139.18 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 17.85 14.87 20.01 18.61 11.27 65.13 12.98 24.54 -47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..